Engage with a challenging session focused on complex calcified lesion interventions. Topics include innovative triple burr techniques, OCT insights into resistant lesions, volume reduction strategies, eccentric calcium management, and IVUS-guided left main calcified lesion treatment, highlighting practical approaches to difficult cases.

This session offers a detailed exploration of drug-coated balloon (DCB) use in non-left main true bifurcation lesions. Learn to define suitable lesion characteristics for provisional stenting, understand stepwise procedural strategies minimizing implanted material, and appreciate the role of intravascular imaging in assessing bifurcation complexity and optimizing...

This session addresses advanced leaflet modification techniques to prevent coronary obstruction during TAVI. Learn from detailed cases involving valve-in-valve interventions, treatment of failed stentless valves, homograft management, and dedicated devices for leaflet modification prior to valve-in-valve and valve-in-valve-in-valve procedures.

This session addresses the complexities and innovative approaches to managing high coronary risk during TAVI procedures. It features advanced techniques such as the double chimney-stent method, valve-in-valve strategies to prevent coronary obstruction, and challenging cases involving TAVI-in-TAVI. These insights provide practical guidance for interventionalists navigating high-risk...

An 80-year-old man underwent percutaneous coronary intervention with a bare-metal stent for severe stenosis at proximal left anterior descending coronary artery 13 years ago. In-stent restenosis was treated by a drug-eluting stent 1 year later...

Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice....

Alex Sticchi & Jonathan Curio provide their take on the clinical trial presented by Gregg W. Stone at the American College of Cardiology Scientific Sessions (ACC.23/WCC).

Aaysha Cader provides her take on the Short-CUT trial presented by Suzanne J. Baron at TCT 2025, in San Francisco.

Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.

Jonathan Curio provides his take on the MitrAI score study which was presented by Luigi Biasco at ESC Congress 2024 in London.

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...